Smooth Drug Development January 2025 News Release

Monthly News – January 2025

At Smooth Drug Development, we are excited to share the latest updates and achievements from January 2025:

New Projects

We are delighted to announce several new collaborations:

• Signed contracts for a Phase I study for medical writing services with Daratumumab and a bioequivalence study with Azithromycin.
• Secured a contract to write abstracts and posters based on the results of the Venetoclax study.

Clinical and Scientific Departments News:

Our clinical teams continue to deliver outstanding progress:

• Independent audits were successfully conducted in the Phase II trial in flu.
• The international phase III clinical trial of the original drug for patients with chronic myeloid leukemia reported results after one year of treatment.
• 92 patients were enrolled in the Pembrolizumab trial.

Business Development News:

Our Business Development team ended the year with active participation in key industry events:

• Our team will attend the Clinical Trials Summit of Pakistan in February 2025.
• We have launched our official Telegram channel. Please join us for the latest updates.